肥胖者胰高血糖素抑制受损与胰岛素敏感性及β细胞功能下降平行
该研究在275例糖耐量各异的肥胖西班牙裔美国人中,评估血浆胰高血糖素水平与胰岛素敏感性及分泌的关系。结果显示,胰高血糖素/胰岛素比值随糖耐量恶化而下降,且与胰岛素抵抗和β细胞功能障碍严重程度相关,提示胰岛素介导的胰高血糖素抑制受损。
要点
- 肥胖者空腹胰高血糖素/胰岛素比值随糖耐量恶化而降低。
- OGTT中胰高血糖素水平随胰岛素抵抗加重而升高。
- 胰高血糖素/胰岛素比值与胰岛素敏感性及β细胞功能相关。
核心结论
- 肥胖者胰岛素介导的胰高血糖素分泌抑制受损,且随糖耐量恶化而加重,与胰岛素抵抗和β细胞功能障碍严重程度平行。
研究设计与样本
- 研究纳入275例糖耐量各异的肥胖西班牙裔美国人,均行2小时口服葡萄糖耐量试验(OGTT),其中90例接受高胰岛素-正葡萄糖钳夹。
主要发现
- 空腹血浆胰高血糖素水平在正常糖耐量、糖尿病前期和2型糖尿病肥胖者中相似,但空腹胰高血糖素/胰岛素比值从正常糖耐量到糖尿病前期再到2型糖尿病进行性下降(9.28 ± 0.66 vs 6.84 ± 0.44 vs 5.84 ± 0.43;P < 0.001)。
- OGTT期间空腹和2小时血浆胰高血糖素水平进行性升高,并与胰岛素抵抗严重程度(Matsuda指数和钳夹法)呈正相关。
- 空腹胰高血糖素/胰岛素比值随胰岛素敏感性和β细胞功能恶化而下降,与全身胰岛素敏感性(Matsuda指数,r = 0.81;P < 0.001)和β细胞功能(r = 0.35;P < 0.001)相关。
- 胰高血糖素/胰岛素比值还与OGTT 60分钟和120分钟时的β细胞功能相关(r = -0.47;P < 0.001 和 r = -0.32;P < 0.001)。
临床怎么用
- 在肥胖患者中评估糖耐量时,可关注胰高血糖素/胰岛素比值作为反映胰岛素抵抗和β细胞功能受损的辅助指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To examine the relationship between plasma glucagon levels and insulin sensitivity and insulin secretion in obese subjects. METHODS: Suppression of plasma glucagon was examined in 275 obese Hispanic Americans with varying glucose tolerance. All subjects received a 2-hour oral glucose tolerance test (OGTT) and a subset (n = 90) had euglycemic hyperinsulinemic clamp. During OGTT, we quantitated suppression of plasma glucagon concentration, Matsuda index of insulin sensitivity, and insulin secretion/insulin resistance (disposition) index. Plasma glucagon suppression was compared between quartiles of insulin sensitivity and beta-cell function. RESULTS: Fasting plasma glucagon levels were similar in obese subjects with normal glucose tolerance (NGT), prediabetes, and type 2 diabetes (T2D), but the fasting glucagon/insulin ratio decreased progressively from NGT to prediabetes to T2D (9.28 ± 0.66 vs 6.84 ± 0.44 vs 5.84 ± 0.43; P < 0.001). Fasting and 2-hour plasma glucagon levels during OGTT progressively increased and correlated positively with severity of insulin resistance (both Matsuda index and euglycemic hyperinsulinemic clamp). The fasting glucagon/insulin ratio declined with worsening insulin sensitivity and beta-cell function, and correlated with whole-body insulin sensitivity (Matsuda index, r = 0.81; P < 0.001) and beta-cell function (r = 0.35; P < 0.001). The glucagon/insulin ratio also correlated and with beta-cell function during OGTT at 60 and 120 minutes (r = -0.47; P < 0.001 and r = -0.32; P < 0.001). CONCLUSION: Insulin-mediated suppression of glucagon secretion in obese subjects is impaired with increasing severity of glucose intolerance and parallels the severity of insulin resistance and beta-cell dysfunction.
引用
- Chen X, Maldonado E, DeFronzo RA, et al. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function. J Clin Endocrinol Metab. 2021. PMID: 33524152. doi:10.1210/clinem/dgab019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。